Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Capital Expenditures (2022 - 2026)

HeartSciences (HSCS) has disclosed Capital Expenditures for 3 consecutive years, with $48799.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Capital Expenditures rose 542.77% year-over-year to $48799.0, compared with a TTM value of $57593.0 through Apr 2025, down 10.65%, and an annual FY2025 reading of $3157.0, down 95.1% over the prior year.
  • Capital Expenditures was $48799.0 for Q2 2024 at HeartSciences, up from $8794.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $48799.0 in Q2 2024 and bottomed at $1952.0 in Q4 2023.
  • Average Capital Expenditures over 3 years is $11823.3, with a median of $7247.0 recorded in 2022.
  • The sharpest move saw Capital Expenditures plummeted 32.25% in 2023, then skyrocketed 542.77% in 2024.
  • Year by year, Capital Expenditures stood at $7247.0 in 2022, then tumbled by 73.06% to $1952.0 in 2023, then soared by 2399.95% to $48799.0 in 2024.
  • Business Quant data shows Capital Expenditures for HSCS at $48799.0 in Q2 2024, $8794.0 in Q1 2024, and $1952.0 in Q4 2023.